Resumption of Winthrop Pharma Senegal by MediS laboratories.
-New development prospects are opening up for the Winthrop Pharma Senegal (WPS) company, its factory and its employees.-
Dakar, April 17,2017th - MédiS and Sanofi today announced the purchase of Sanofi's shares in the WPS company by the MédiS group, which is now MédiS in Senegal.
Arabie saoudite
Arabie saoudite
Sénégal
Sénégal
Tunisie
Tunisie
The Laboratories MédiS Launch the First Recombinant Human Erythropoietin Produced in Tunisia
On March 2, 2015, MédiS obtained authorization to market the first human-origin recombinant alpha erythropoietin (EPO), marking a significant milestone in the Tunisian pharmaceutical industry. This achievement made MédiS the first Tunisian laboratory to produce and market its biosimilar EPO under the name EPOMAX®.